Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
Applied DNA Sciences (NASDAQ:APDN) has announced the rescheduling of its intra-quarter webcast and investor update call from June 3 to June 17, 2025. The postponement is due to the implementation of a reverse stock split that will take effect on June 2, 2025. The webcast will begin at 4:30 p.m. Eastern Time and will include prepared remarks from the management team, followed by a Q&A session with sell-side analysts and institutional investors. The event will be accessible via phone and webcast, with replay options available for 7 days after the call. An accompanying slide presentation will be available during the webcast and on the company's investor relations website.
["-"]Applied DNA Sciences (NASDAQ:APDN) ha annunciato il rinvio della sua webcast trimestrale e della call di aggiornamento per gli investitori, inizialmente prevista per il 3 giugno, al 17 giugno 2025. Il posticipo è dovuto all'attuazione di un split azionario inverso che entrerà in vigore il 2 giugno 2025. La webcast inizierà alle 16:30 ora della costa orientale e comprenderà interventi preparati dal team di gestione, seguiti da una sessione di domande e risposte con analisti sell-side e investitori istituzionali. L'evento sarà accessibile tramite telefono e webcast, con la possibilità di rivederlo per 7 giorni dopo la chiamata. Una presentazione a slide sarà disponibile durante la webcast e sul sito web delle relazioni con gli investitori della società.
Applied DNA Sciences (NASDAQ:APDN) ha anunciado el cambio de fecha de su webcast e informe para inversores del trimestre, originalmente programado para el 3 de junio, al 17 de junio de 2025. El aplazamiento se debe a la implementación de una consolidación de acciones inversa que entrará en vigor el 2 de junio de 2025. El webcast comenzará a las 4:30 p.m. hora del este e incluirá comentarios preparados por el equipo directivo, seguidos de una sesión de preguntas y respuestas con analistas sell-side e inversores institucionales. El evento será accesible por teléfono y webcast, con opciones de repetición disponibles durante 7 días después de la llamada. Una presentación en diapositivas estará disponible durante el webcast y en el sitio web de relaciones con inversores de la compañía.
Applied DNA Sciences (NASDAQ:APDN)는 6월 3일로 예정되었던 분기 중 웹캐스트 및 투자자 업데이트 콜을 2025년 6월 17일로 연기한다고 발표했습니다. 이번 연기는 2025년 6월 2일에 시행되는 역병합 주식 때문입니다. 웹캐스트는 동부 시간 오후 4시 30분에 시작되며 경영진의 준비된 발언과 이어서 셀사이드 애널리스트 및 기관 투자자들과의 질의응답 세션이 포함됩니다. 이 행사는 전화와 웹캐스트를 통해 참여할 수 있으며, 콜 이후 7일간 재청취가 가능합니다. 웹캐스트 동안 및 회사 투자자 관계 웹사이트에서 슬라이드 발표 자료도 제공됩니다.
Applied DNA Sciences (NASDAQ:APDN) a annoncé le report de sa webdiffusion et de sa conférence de mise à jour pour les investisseurs, initialement prévues le 3 juin, au 17 juin 2025. Ce report est dû à la mise en œuvre d'un fractionnement inversé d'actions qui prendra effet le 2 juin 2025. La webdiffusion débutera à 16h30, heure de l'Est, et comprendra des remarques préparées par l'équipe de direction, suivies d'une session de questions-réponses avec des analystes sell-side et des investisseurs institutionnels. L'événement sera accessible par téléphone et webdiffusion, avec des options de rediffusion disponibles pendant 7 jours après l'appel. Une présentation accompagnée de diapositives sera disponible pendant la webdiffusion et sur le site des relations investisseurs de la société.
Applied DNA Sciences (NASDAQ:APDN) hat die Verschiebung seines Webcasts und Investor-Updates im Quartal vom 3. Juni auf den 17. Juni 2025 bekanntgegeben. Die Verschiebung erfolgt aufgrund der Umsetzung eines Reverse Stock Splits, der am 2. Juni 2025 wirksam wird. Der Webcast beginnt um 16:30 Uhr Eastern Time und umfasst vorbereitete Redebeiträge des Managementteams, gefolgt von einer Fragerunde mit Sell-Side-Analysten und institutionellen Investoren. Die Veranstaltung ist telefonisch und per Webcast zugänglich, mit Wiedergabeoptionen für 7 Tage nach dem Anruf. Eine begleitende Präsentation mit Folien wird während des Webcasts und auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update call to June 17, 2025, from June 3, 2025, to allow for the implementation of a reverse stock split that will become effective on June 2, 2025.
Prepared remarks by members of the Applied DNA management team will be followed by a live question-and-answer session with the Company's sell-side analysts and institutional investors.
Webcast and Conference Call Date & Time: Tuesday, June 17 @ 4:30 p.m. Eastern Time
Dial In:
Domestic callers (toll-free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll-free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Ky09znsL
A replay of the conference call will be available for 7 days following the conclusion of the call:
Replay for domestic callers (toll-free): 877-344-7529, replay access code 3446494
Replay for international callers: 412-317-0088, replay access code 3446494
Replay for Canadian callers (toll-free): 855-669-9658, replay access code 3446494
An accompanying slide presentation will be embedded in the webcast (live and replay) that will also be accessible as a stand-alone document via the 'Company Presentations' page of the Applied DNA investor relations website. The webcast replay of the call will be available approximately one hour after the end of the call on the 'Company Events' page.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/
SOURCE: Applied DNA Sciences, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Applied DNA (APDN) conducting its reverse stock split in 2025?
What is the new date for Applied DNA's (APDN) investor update call?
How long will the replay of Applied DNA's June 2025 investor call be available?
What is the toll-free number for domestic callers to join Applied DNA's investor call?
